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Chapter 1.0 Introduction to Marine Toxins and Toxicology 
Marine natural toxins are commonly classified as natural chemicals or substances 
produced by specific marine organisms that may cause deterring or harmful effects on 
other organisms. Whether toxin productions are triggered by natural cycle, 
environmental changes or produced by organisms primarily for the ecological counter 
balance of predator-prey relationships, humans in many ways have become the 
unfortunate victims in this cycle. Throughout the years, intoxication from marine toxins 
occur globally with higher prevalence usually occurring in regions of low monitoring 
regulations and surveillances. A wider pre-empted knowledge of the likely occurrence 
of certain intoxications either stem from past experiences or as awareness by authorities 
have proven to be an effective risk-reduction approach.  
The marine environment with its harsh conditions predominantly harbours some of the 
most life-threatening toxins known to mankind. Toxins produced by tiny marine 
organisms such as bacteria, dinoflagellates and micro algae are amongst the prevailing 
causes of seafood poisoning. To date, there are an estimate of 60-80 toxic marine 
microalgae that exist globally, and dinoflagellate accounts for 75% of all marine toxins 
related poisoning1). Marine toxins are usually classified according to their specific 
producers, vector-borne producers, chemical-based categories or clinical syndromes etc. 
Some common marine toxins are ciguatera fish poisoning, scombroid poisoning, 
pufferfish poisoning, shellfish poisoning which include diarhetic shellfish poisoning 
(DSP), paralytic shellfish poisoning (PSP), neurotoxic shellfish poisoning (NSP), 
amnesic shellfish poisoning (ASP) and azaspiracid shellfish poisoning (AZP), and the 
much rarer but potent poisoning such as seaweed poisoning and turtle poisoning.  
As one of the frequent intoxicating agent in the Pacific, ciguatera poisoning is a 
neurotoxic form of ichthyosarcotoxism that can result from consuming flesh of certain 
species of barracuda, grouper, snapper, mackerel, moray2,3) etc. The principle 
neurotoxic agent, ciguatoxins (CTX), are a group of lipophilic, polycyclic polyether 
toxins consisting of 13 or 14 rings fused into rigid ladder-like structures.4) (Figure 1.1). 
Over the years, many analogues have been isolated or modified.5,6,7) Different 
geographical locations accounts for different CTX forms, however, the Pacific 
2 
 
ciguatoxin-1 (P-CTXs) and the Caribbean ciguatoxin-1 (C-CTXs) seems to be the 
common CTXs and are known to possess considerable potency, though neurological 
activities vary among analogue types.8) These sodium channel activators are produced 
by dinoflagellate of genus Gambierdiscus which are bioaccumulated in the tissues of 
higher hierarchical organisms via the marine food chain.5,9,10)  
On the onset, victims of ciguatera poisoning often suffer from nausea, vomiting, 
abdominal pain and neurologic symptoms such as tingling fingers or toes. Victims may 
also experience pathognomonic conditions of cold allodynia caused by ciguatoxins’ 
specific target on cold pain pathways in the primary sensory neurons.11) Ciguatera has 
no cure. Symptoms usually go away in days or weeks however; severe cases can last for 
few years. Since the producer ecologically strives in warmer regions, ciguatera 
outbreaks often occur in tropical and subtropical countries most of which rely on 
seafood and especially fresh fish as their source of daily protein. Ciguatera is amongst 
the most common non-bacterial food poisoning with an estimated global case of 50,000-
500,000 annually.12)  
 
 
 
 
 
 
 
 
 
 
Figure 1-1. Structures of ciguatoxins.  
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Scombroid poisoning or usually known as histamine food poisoning is caused by 
consumption of mishandled fish, particularly common in fish with high levels of free 
histidine in their muscle tissue. These may include the scombridae family like tunas 
(Thunini tribe), bonitos (Sardini tribe), mackerel (Scombrini tribe) and others such as 
mahi mahi (Coryphaena spp.), sardines (Sardinella spp.) herring (Clupea spp.).13) 
Poisoning is implicated when higher levels of naturally occurring free histidine (enzyme 
substrate) is converted to histamine by bacterial histidine decarboxylase at mid cooling 
temperature (Figure 1-2) Though endogenous histamine is important in normal 
physiological functions, an increase of histamine levels in the circulatory system from 
contaminated food may trigger histamine receptors to activate biological responses and 
produce various toxicological effects. Symptoms may include flushing, rash (urticaria), 
hypotension, headache, tachycardia, abdominal cramps, diarrhoea, vomiting, pain, 
itching, oral burning sensation, peppery taste, nausea, swelling of tongue.14)  
Severe effects usually subside following antihistamine treatment therapy which include 
H1 antagonists (e.g. diphenhydramine) and H2 antagonists (e.g. cimetidine), however, 
for mild cases only maintenance support (eg. fluid replacements) is required.15)  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2. Formation of histamine by decarboxylation 
of histidine.  
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Shellfish poisoning (SFP) is a generic term used to describe the phytotoxic poisoning 
caused by the consumption of contaminated shellfish such as oyster, clams, scallops or 
mussels. SFP are categorised into five groups namely a) paralytic shellfish toxins 
causing PSP; b) diarrheic shellfish toxins causing DSP; c) amnesic shellfish toxins 
causing ASP; d) neurotoxic shellfish toxins causing NSP; and e) azaspiracid shellfish 
toxins causing AZP.16,17) Each of the group is characterized by the chemicals or toxic 
compounds that are implicated in the contaminated shellfish. Besides their different 
mode of actions, chemical and structural properties of the principle toxins and their 
analogues also vary in their structures and biological potency.18,19) Some classes display 
specific symptoms while others are non-specific and seem to show merging 
neurological and gastrointestinal symptoms. 
 
As one of the common SFP, PSP is categorized as the ingestion of contaminated 
shellfish containing tetrahydropurines related toxins such as saxitoxin and its analogues 
(Figure 1-3) which are produced by the dinoflagellate genus Alexandrium. PSP toxins 
display pharmacological effects by inhibiting the voltage-gated sodium channel which 
involve slowing or abolishing the propagation of the action potential in plasma 
membrane of excitable cells. The very high selectivity and affinity mode of action 
between certain PSP toxins and the sodium ion channel protein makes PSP toxins few 
of the most potent marine biotoxins in shellfish poisoning. Symptoms of PSP range 
from parathesias sensation, loss of muscle coordination, speech defects, nausea, 
vomiting, respiratory paralysis and death.4)  
 
 
 
 Figure 1-3. Structures of STX and its analogues. 
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Chapter 2-1.0 Introduction of Tetrodotoxin (TTX) 
Tetrodotoxin (TTX) is a well-known natural toxin and the fatal agent in TTX poisoning. 
TTX and its analogues are distributed in both marine and terrestrial animals such as 
pufferfish,20,21) marine nails,22) blue-ringed octopus,23) starfish,24) crabs,25) sea slugs,26) 
clams,27,28) mussels and oysters,29) frogs,30,31) and newts.32,33) TTX blocks the voltage-
gated sodium channels which results in the incapacitation of nerve conduction and 
muscle action potentials, causing progressive paralysis and death due to failure of the 
respiratory system.34,35) Due to its neurological properties, TTX was also developed as a 
therapeutic agent to ease off severe pain in cancer patients.36)  
 
TTX, as the principal cause of pufferfish poisoning, are reported to have been originated 
from the TTX-producing bacteria such as in genus Vibrio spp. Aeromonas spp. and 
Pseudomonas spp. and is accumulated into the marine invertebrate and pufferfish via 
the food chain.37,38) The role of TTX in animals has been an ongoing theme of study for 
many years. Among other reasons, the obvious roles of TTX are for protection, defense 
and helps in foraging. Newts for instance, use TTX as part of its defense strategy to 
void off predators39) and TTX is used to capture mobile prey as demonstrated by 
flatworms in Guam.40)  
 
Apart for TTX, there are more than 30 analogues already been discovered. The major 
analogues (Figure 2-1), can be classified into (1) hemilactal type analogues, (2) 5-
deoxy-10,7-lactone type analogues, (3) 4,9- and 4,4a-anhydro type analogues and (4) 
tetrodonic acid type analogue.41,42)  
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Based on the structures of these analogues, few researchers have also attempted to 
predict a stepwise oxidative pathway of TTX in marine animals.42) This was made 
possible by the recently discovered C5–C10 directly bonded TTX analogues in newts, 
which suggested a monoterpene origin of TTX.43)  
 
Previous mouse bioassay toxicity experiments have established the LD50 (50% lethal 
dose, mice, i.p.) of TTX and few analogues. For instance, TTX being more potent than 
other analogues affects mice at LD50 of 10 μg/kg34), while its analogues such as 11-
deoxyTTX44)  and 6,11-dideoxyTTX45)  have LD50 of 70 μg/kg, and 420 μg/kg, 
respectively and 5,6,11-trideoxyTTX, a LD99 of 750 μg/kg.46) The toxicity of 11-
oxoTTX was initially reported at 120 μg/kg (minimum lethal dose, mice, i.p.),47) 
however, experiments on rat skeletal muscle fibers revealed an ED50 (50% effective 
dose) of 0.7 nM compared to TTX 4.1 nM48) and smaller Kd values of 11-oxoTTX (to 
rat brain membrane) compared to TTX49) which suggested that 11-oxoTTX is much 
more potent than TTX. The potency of TTX and its analogue such as 11-oxoTTX 
highlighted the importance of proper regulations in seafood safety, especially in 
Figure 2-1. Structures of TTX and its analogues. 
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pufferfish species. Pufferfish poisoning has been reported in Asian countries such as 
Hong Kong,50) Thailand,51) Bangladesh,52) and Japan,53) Eastern Mediterranean Sea,54) 
Suez Canal region,55) and also in the United States mainly from illegally imported 
pufferfish.56,57) Due to the increase of global occurrences especially in regions not been 
recorded in the past, the need for proper regulation and scientific research is vital. 
 
 Unlike ciguatera and other seafood poisoning, the documentation of pufferfish was not 
well represented in the South Pacific, although few occurrences that fits its description 
were reported to have taken place in localized rural areas.58) In the Solomon Islands, no 
clear records were established to date of the victims who may have suffered from 
pufferfish poisoning. Probably, the dangers of pufferfish consumption may have been 
widely known due to past intoxication, thereby reducing the cases of pufferfish 
poisoning. However, since most people eat seafood, especially fish as a protein source 
and along with the socioeconomic pressures that may affect food security and possibly 
alter food selectivity, the investigation of TTX in common Solomon Islands pufferfish 
is of great importance. Having a clear information based on scientific evidence will 
definitely help citizens refrain from consuming toxic pufferfish species, and thus reduce 
the potential risk of pufferfish poisoning. Like TTX, the paralytic shellfish toxins can 
also be accumulated by few pufferfish. Past occurrences of saxitoxin (STX) and 
decarbamoyl STX (dcSTX) in pufferfish were reported in South-eastern Asia, Japan59-
61) and the United States.62) 
 
In this research project, Solomon Islands pufferfish Arothron hispidus and A. 
nigropunctatus were investigated for TTX and its analogues, as well as STX and its 
analogues for the first time, using high resolution hydrophilic interaction 
chromatography (HR-HILIC) LC-MS. In a parallel experiment, the same species from 
Okinawa, Japan, were also investigated for comparison with those from the Solomon 
Islands. Moreover, since few organs of Diodon. holocanthus are officially allowed for 
consumption in Japan,63) Solomon Islands’ D. holocanthus species were also collected 
to examine the possible presence of TTXs and its analogues.  
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2-2.0 Procedure 
2-2.1 Sampling and Test Materials 
Field collection of the samples were carried out in May and July 2014, in the Tomba 
group of islets (latitude 8.427° S, longitude 157.929° W), situated along the coastal 
open waters on the other side of the enclosed Marovo Lagoon, Solomon Islands. The 
samples consisted of three specimens of A. hispidus, three specimens of A. 
nigropunctatus and two specimens of D. holocanthus. The gender, body length and 
body weight of each specimen are recorded in Tables 2-1 to 2-3 and 2-6. Soon after 
collection, each of the pufferfish specimen was dissected into various organs such as 
skin, liver, gonad, stomach, intestine, flesh and the whole organ or a part (where organ 
size is too large) soaked in separate disposable plastic tube (TPP, Trasadingen, 
Switzerland) containing approximately 15 mL of ethanol-water (7:3, v/v). Samples were 
then transported to Tohoku University, Sendai, Japan. Note that samples were 
transported at room temperature due to the lack of proper freezing equipment and longer 
(two weeks) transportation period which involved air-shipments and formal quarantine 
checkups by authorities from Solomon Islands and Japan. Upon arrival, samples were 
kept below −25 °C until use.  
 
Table 2-1. Characterisation of A. hispidus specimens from Solomon Islands 
A. hispidus specimens Gender Body Length Body Weight 
A. hispidus No.1 Female 19 cm 130 g 
A. hispidus No.2 Male 17 cm 118 g 
A. hispidus No.3 Male 18 cm 120 g 
 
Table 2-2. Characterisation of A. nigropunctatus specimens from Solomon Islands 
A. nigropunctatus specimens Gender Body Length Body Weight 
A. nigropunctatus No.1 Female 19 cm 163 g 
A. nigropunctatus No.2 Male 37 cm 320 g 
A. nigropunctatus No.3 Female 20 cm 180 g 
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Table 2-3. Characterisation of D. holocanthus specimens from Solomon Islands 
D. holocanthus specimens Gender Body Length Body Weight 
D. holocanthus No.1 Female 30 cm 310 g 
D. holocanthus No.2 Male 35 cm 350 g 
 
 
For comparison, four living specimens of A. nigropunctatus and three living specimens 
of A. hispidus were collected from April to June 2015 in Okinawa, Japan and were sent 
to Tohoku University. Upon arrival, each specimen was dissected into organs and kept 
frozen at −25 °C until use. The characterisation of pufferfish from Okinawa, Japan were 
recorded in Tables 2-4, 2-5 and 2-7. 
 
Table 2.4. Characterisation of A. hispidus specimens from Okinawa, Japan 
A. hispidus specimens Gender Body Length Body Weight 
A. hispidus No.1 Male 17 cm 112 g 
A. hispidus No.2 Female 17 cm 124 g 
A. hispidus No.3 Male 10 cm 31 g 
 
 
Table 2-5. Characterisation of A. nigropunctatus specimens from Okinawa, Japan 
A. nigropunctatus specimens Gender Body Length Body Weight 
A. nigropunctatus No.1 Male 15 cm 67 g 
A. nigropunctatus No.2 Male 21 cm 375 g 
A. nigropunctatus No.3 Male 14 cm 70 g 
A. nigropunctatus No.4 Female 16 cm 130 g 
 
 
 
 
 
 
 
 
 
10 
 
Table 2-6. Solomon Islands A. hispidus No.1-3, A. nigropunctatus No.1-3  
and D. holocanthus No.1-2 (weight in grams) 
Specimens Skin Liver Gonad Stomach Intestine Flesh 
A. hispidus No.1 24.9 g 8.0 g 82.5 g 2.8 g 0.8 g  
A. hispidus No.2 17.9 g 8.0 g 0.7 g 1.0 g   
A. hispidus No.3 13.7 g 4.6 g 0.5 g 2.3 g 0.4 g 7.9 g 
A. nigropunctatus No.1 21.9 g 3.7 g 2.8 g 1.5 g 0.5 g  
A. nigropunctatus No.2 3.4 g 20.4 g 16.0 g    
A. nigropunctatus No.3 9.2 g 3.9 g 0.7 g 2.5 g   
D. holocanthus No.1 21.7 g 18.5 g 19.5 g 7.0 g   
D. holocanthus No.2 22.2 g 28.5 g 17.0 g 11.0 g 29.5 g 21.3 g 
 
 
Table 2-7. Okinawan A. hispidus No. 1-3 and A. nigropunctatus No. 1-4  
(weight in grams). 
Specimens Skin Liver  Gonad Stomach Intestine Flesh Spleen 
A. hispidus No.1 17.6 g 2.7 g 0.3 g 1.2 g 7.4 g 6.8 g 0.3 g 
A. hispidus No.2 15.0 g 2.0 g 0.9 g 1.5 g 5.5 g 7.5 g 0.2 g 
A. hispidus No.3 8.6 g 1.5 g 0.1 g 0.9 g 2.4 g 3.0 g 0.09 g 
A. nigropunctatus No.1 37.7 g 0.4 g 0.8 g 3.2 g 0.5 g 26.2 g 0.3 g 
A. nigropunctatus No.2 67.1 g 29.9 g 14.2 g 5.8 g 50.4 g 38.8 g 0.5 g 
A. nigropunctatus No.3 20.2 g 1.3 g 0.5 g 0.8 g 4.5 g 8.8 g 0.4 g 
A. nigropunctatus No.4 12.4 g 2.6 g 1.1 g 1.7 g 5.3 g 8.0 g 0.3 g 
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The pictures of few pufferfish specimens used in the study and a general procedure 
involved in sample preparations, toxin extraction and preliminary analysis of toxins are 
outlined in Scheme 2-1. 
 
 
 
 
2-2.2 Standards and Reagents 
The standard used in the analysis was a semi-purified TTXs mixture prepared from the 
ovary of Takifugu poecilonolus which was treated with charcoal column,42,46) while the 
authentic 11-oxoTTX was obtained by a chemical oxidation of TTX.49) 
A highly purified TTX was used to create a calibration curve for HR-LC-MS analysis. 
Standard mixture of STX, dcSTX, and neoSTX were prepared (approved under AOAC 
guidelines) by Prof. Emeritus Dr. Yasukatsu Oshima.64) Activated charcoal and all the 
solvents for LC and the reagents were purchased from Wako Pure Chemical Industries 
(Osaka, Japan), while the ammonium formate for LC-MS, heptafluorobutyrate acid, and 
acetonitrile for LC-FLD were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
 
 
 
Scheme 2-1. General procedure used in the TTX analysis. 
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2-2.3 Preliminary Liquid Chromatography-Fluorescent Detection (LC-FLD) Analysis 
of TTXs in the Skin of A. hispidus from the Solomon Islands 
 
From the ethanol-water (7:3, v/v) solution used as a preserving solvent mixture for the 
skin of the Solomon Islands A. hispidus, an aliquot of 0.5 mL was acidified with acetic 
acid, dried in vacuo, and then dissolved in 0.5 mL of 0.05 M acetic acid. After 
centrifugation, a small volume of supernatant was diluted ten-fold with 0.05 M acetic 
acid. An aliquot (2 μL) of the diluted solution was then applied to the LC-FLD for 
TTXs measurement. Likewise, a part (0.25 g) of the actual skin specimen preserved in 
the tube of ethanol solution was extracted with 1.25 mL of 0.2 M acetic acid (v/v) in 
boiling water. The extract was centrifuged at 15,000 × g and an aliquot (2 μL) of the 
supernatant was applied to the LC-FLD.65,66) 
 
2-2.4 Preparation of samples for HR-LC-MS Analysis 
 
2-2.4.1 Ethanol-water (7:3, v/v) solution (preserving solvent mixture) from the organs 
of Solomon Islands Pufferfish 
 
From the preserving solvent mixture (15 mL of ethanol-water (7:3, v/v) solution) of 
each of the pufferfish organs, an aliquot of 0.5 mL was separately mixed with 5 μL of 
acetic acid, and dried in vacuo. The dried residue was dissolved in 0.5 mL of 0.05 M 
acetic acid and neutralized with 1 M NaOH aqueous solution. The neutralized solution 
was then applied to the activated charcoal with a column volume of 250 μL packed in a 
glass pipette that was pre-equilibrated with water. After further washing the charcoal 
with 0.75 mL (3 volumes) of water, TTXs were eluted with 1.5 mL of acetic acid-
ethanol-water (2:50:48, v/v) solution mixture. A part (50 μL) of this eluate was dried in 
vacuo and dissolved in 50 μL of 0.05 M acetic acid, and then filtered through 
Cosmospin Filter H (Nacalai Tesque, Inc., Kyoto, Japan). After the filtrate was diluted 
with 0.05 M acetic acid, a part of this solution was used for HR-LC-MS. From the LC-
FLD quantitative analysis, the estimated recovery of TTXs in the organs from the 
activated charcoal was approximately 70%. This recovery ratio was also used in the 
calculation of the final TTXs concentrations in the organs from Solomon Islands 
pufferfish. 
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2-2.4.2 Organs of Pufferfish from both Solomon Islands and Okinawa, Japan 
 
A part (0.25 g) of the organ from each specimen was weighed out and homogenized 
with 1.25 mL of acetic acid-water (1:99, v/v). The mixture was then boiled for 10 
minutes in a 1.5 mL micro (Eppendorf) tube, and centrifuged at 15,000 × g for 15 
minutes at 4 °C. Half (0.75 mL) of the supernatant was neutralized with 1 M NaOH, and 
then applied to the pre-equilibrated charcoal (column volume 250 μL). Further steps 
involved in sample treatment follows the same procedure outlined in Sections 2.2.3 and 
2.2.4.1. 
 
2-2.5 LC-FLD for TTXs 
 
Post-column LC-fluorescent detection (LC-FLD) for TTXs was performed as 
previously described65,66) (Figure 2-2). Briefly, the LC conditions were as follow: 
Develosil C30 UG-5 (0.46 cm i.d. × 25 cm) (Nomura Chemical, Seto, Japan) with 30 
mM ammonium heptafluorobutyrate buffer (pH 5.0) and 10 mM ammonium formate 
buffer (pH 5.0) containing 1% (v/v) acetonitrile at a flow rate of 0.4 mL/min; for the 
post column reaction 4 M NaOH at a flow rate of 0.7 mL/min to be heated at 105 °C in 
the stainless tube (0.46 mm i.d. × 3.5 m). The chromatography was performed at 20 °C. 
The derived fluorophores by post column reaction were detected by a Jasco FP2025 
plus fluoromonitor (Jasco, Tokyo, Japan) with the excitation wavelength set at 365 nm 
and emission wavelength at 510 nm. 
  
Diagram adapted from Yasumoto T and Michishita T. Agric. Biol. Chem. 1985 49, 3077–3080. 
Figure 2-2. A flow diagram of LC-FLD used in the TTX investigation.  
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2-2.6 High Resolution LC-MS and LC-MS/MS for TTXs 
 
HILIC LC-MS and MS/MS methods were performed as reported by Yotsu -Yamashita 
M, et al.42) The LC system for TTXs was a Shimadzu Nexera UHPLC System 
(Shimadzu, Kyoto, Japan) and consisted of LC-10AD pump (Shimadzu, Kyoto, Japan), 
autosampler (SIL-30AC, Shimadzu) and TSKgel Amide-80 column (150 × 2.0 mm i.d., 
particle size 5 μm, Tosoh, Tokyo, Japan). The mobile phase was 16 mM ammonium 
formate in water/acetonitrile/formic acid (30:70:0.002, v/v) with a flow rate of 0.2 
mL/min at 28 °C in the isocratic mode with an injection volume of 2–3 μL and run time 
of 25 min.  
 
The LC system connected to a Q-TOF MS spectrometer, MicrOTOFQII (Bruker 
Daltonics, Bremen, Germany) was equipped with an ESI source and consisted of the 
following MS spectrometer conditions: positive ionization mode, dry gas: nitrogen 7 
L/min, dry temperature: 180 °C, nebulizer:1.6 Bar, capillary: −4500 V. All the preset 
ions (listed below) corresponding to the [M + H]+ ions were analyzed in the extracted 
ion chromatograms (EIC). Ions were set at m/z 320.1088 (TTX, 4-epiTTX), 302.0983 
(4,9-anhydroTTX), 304.1139 (11-deoxyTTX, 5-deoxyTTX), 288.1190 (6,11-
trideoxyTTX, 5,11-dideoxyTTX), 272.1241 (5,6,11-trideoxyTTX, 4-epi-5,6,11-
trideoxyTTX) and 254.1135 (4,9-anhydro-5,6,11-trideoxyTTX, 4,4a-anhydro-5,6,11-
trideoxyTTX), 336.1038 (11-oxoTTX, 4-epi-11-oxoTTX) and 318.0932 (4,9-anhydro-
11-oxoTTX). While all TTX analogues were quantified by HR-LC/MS based on the 
standard curve for TTX, the peak of 11-oxoTTX and 4-epi-11-oxoTTX in the samples 
from the Solomon Islands seemed to be suppressed by certain compounds eluting at the 
same retention time. Thus, 11-oxoTTX and 4-epi-11-oxoTTX were quantified using 
LC-FLD.  
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Besides 11-oxoTTX and 4-epi-11-oxoTTX, the limit of detection (LOD) for all TTX 
analogues were (S/N > 3, 0.01 μg/g) and their limit of quantitation (LOQ) were (S/N > 
10, 0.03 μg/g), while the LOD and LOQ of 11-oxoTTX and 4-epi-11-oxoTTX were 
0.04 μg/g and 0.14 μg/g, respectively. MS/MS was performed in AutoMS/MS mode 
setting [M + H]+ as the precursor ions. The precursor ions and sweeping collision 
energy were 320.1088 ± 0.1, 36.9–55.4 eV for TTX, and 336.1038 ± 0.1, 38.1–57.1 eV 
for 11-oxoTTX. 
 
2-2.7 High Resolution LC-MS for STXs 
 
STX, dcSTX and neoSTX were analyzed using HR-LC-MS. The LC system for STXs 
was a Shimadzu Nexera UHPLC System (Shimadzu, Kyoto, Japan) and consisted of 
LC-10AD pump (Shimadzu, Kyoto, Japan), autosampler (SIL-30AC, Shimadzu) and 
TSKgel Amide-80 column (150 × 2.0 mm i.d., particle size 5 μm, Tosoh, Tokyo, 
Japan). The mobile phase used in STXs was 2 mM ammonium formate in 
water/acetonitrile/formic acid (30:62:0.0125, v/v) at a flow rate of 0.2 mL/min at 25 °C 
in the isocratic mode with an injection volume of 2.0 μL and run time of 30 min.64)  
The mass spectrometer and its condition were same as those of TTXs analysis described 
above (see section 2-2.6). STX, dcSTX and neoSTX were detected as [M + H]+ ions at 
m/z 300.1415 ± 0.05, 257.1356 ± 0.05, and 316.1365 ± 0.05, respectively. LOD (S/N > 
3) and LOQ (S/N > 10) for STX were 0.02 μg/g and 0.07 μg/g, neoSTX, 0.05 μg/g and 
0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, respectively. 
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2-3.0 Results 
2-3.1 Evaluation of TTX and its analogues in pufferfish from the Solomon Islands 
 
2-3.1.1 Results on preliminary LC-FLD analysis of TTXs in the skin of A. hispidus 
from the Solomon Islands 
 
Due to longer transit time and the lack of proper freezing equipment during flight 
duration, the feasibility of the specimens for analysis were checked as soon as the 
samples arrived at Tohoku University. Practically, there are several stable solvents and 
condition that can give maximum amount of TTXs recovery which were unfortunately 
unavailable in our case. TTX powder is known to be stable in diluted citrate or acetate 
buffer solutions at 1 mg/mL while in aqueous form it is much stable in mild acidic 
solvents of pH 4-5 and is in excellent state when stored in frozen condition.67) On the 
other hand, strong acidic and alkaline conditions can easily decompose the TTX and 
this was avoided during the specimen preservation. Ethanol-water (7:3 v/v) solution was 
used due to its preservative properties especially for marine samples, being polar in 
nature (approx. pH 7) which is fairly soluble for the TTXs and of its ease of 
accessibility.  
 
However, although ethanol may be soluble for TTXs, its hydroxyl group may slightly 
shift the pH towards basic condition which can potentially decompose the TTXs. 
Therefore, a preliminary analysis of TTX was carried out to see if specimens were still 
in good conditions for TTXs analysis or that specimens have been badly decomposed 
during the two weeks of transportation and transit period. Under such conditions and 
during longer period, certain TTX and its analogues are more likely to be hydrolyzed or 
degraded into tetrodonic acid (Figure 2-3) type compounds or other quinazoline related 
compounds,41,68) and this conversion can be detected using LC-FLD for TTXs 65,66) 
without specific pre-purification.  
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In this preliminary analysis, both the preserving ethanol solution of the skin of A. 
hispidus (three specimens) and the skin specimen that was soaked in this preserving 
ethanol solution were analyzed using LC-FLD.69) This procedure was repeated for each 
of the sample specimen from the Solomon Islands. An exemplary LC-FLD 
chromatogram obtained in the skin of the A. hispidus No.3 specimen is shown in Figure 
2-3. Result showed that the peak area of tetrodonic acid type analogues (peak A) in both 
the ethanol solution (Figure 2-3b) and the extract of the skin (Figure 2-3c) was 
approximately 60% to that of TTX (peak C). Since the samples from the Solomon 
Islands may naturally contain a considerable amount of tetrodonic acid even before 
collection, the content of tetrodonic acid as revealed by the peak was assumed to be the 
combination of natural and the hydrolyzed forms of some TTXs compounds. 
 
Other clearly observed peaks included 11-oxoTTX and 4-epi-11-oxoTTX (peak B 
composition), 4,9-anhydro-11-oxoTTX (peak D), 4-epiTTX (peak E) and 4,9-
anhydroTTX (peak F). Despite the partial conversion of TTXs into tetrodonic acid type 
analogues, pufferfish samples transported from the Solomon Islands were still in good 
condition for TTXs analysis as confirmed by this LC-FLD data.69)  
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Figure 2-3. The LC-FLD chromatograms of the skin extracts of the A. hispidus 
No.3 specimen from the Solomon Islands. (a) The TTXs standard solution (5 μL) 
containing TTX 1.0 μg/mL, 4-epiTTX 0.18 μg/mL, and 4,9-anhydroTTX 0.24 
μg/mL (attenuation 3), (b) Aliquot sample (6 μL) prepared from the ethanol-water 
(7:3, v/v) solution used to soak the skin of A. hispidus No.3 specimen (10.5 mL/g) 
(attenuation 6), (c) The sample solution (2 μL) prepared from 0.2 M acetic acid (v/v) 
extract of the skin of A. hispidus No.3 specimen soaked in ethanol solution (5.0 
mL/g) (attenuation 6). A: tetrodonic acid types, B: 11-oxoTTX and 4-epi-11-
oxoTTX, C: TTX, D: 4,9-anhydro-11-oxoTTX, E: 4-epiTTX, F: 4,9-anhydroTTX.  
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2-3.1.2 High Resolution-LC-MS characterization and quantitation of TTX and its 
analogues.  
 
Organs soaked in the preserving solvent were separately extracted with 0.2 M acetic 
acid (v/v) and boiling water. After passing each extract through an activated charcoal  
column, each sample was analyzed using High Resolution (HR) HILIC-LC-MS (Q-TOF 
MS) with the conditions in section 2-2.6. 42,66-72) An example of the mass 
chromatograms with the tolerance width of the ions of TTX and its analogues in the 
skin of A. hispidus (No.3 specimen) are shown in Figure 2-4, while other examples are 
in the appendix p.92-93. TTX and all its analogues were quantified using HR-LC-MS 
based on the calibration curve drawn from the TTX standard.  
 
 
 
 
    
 
 
 
 
Figure 2-4. HR-LC-MS chromatograms (extracted ion chromatograms: EICs) of 
charcoal treated sample solution (2 μL) prepared from the skin of A. hispidus 
No.3 specimen (25 mL/g) from the Solomon Islands soaked in ethanol solution. 
The sample solution contained TTX 1.4 μg/mL, 4-epiTTX 0.30 μg/mL, 4,9-
anhydroTTX 0.80 μg/mL, 5-deoxyTTX 0.13 μg/mL, 6,11-dideoxyTTX 0.03 
μg/mL, 5,11-dideoxyTTX 0.09 μg/mL, 5,6,11-trideoxyTTX and 4-epi-5,6,11-
trideoxyTTX (total of two analogues 1.8 μg/mL), 4,4a-anhydro-5,6,11-
trideoxyTTX 2.7 μg/mL, 11-oxoTTX 0.50 μg/mL, 4-epi-11-oxoTTX 0.50 μg/mL, 
and 4,9-anhydro-11-oxoTTX 0.60 μg/mL. 
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However, based on the HR-LC-MS method, the Solomon Islands samples showed that 
the peak areas of 11-oxoTTX and 4-epi-11-oxoTTX on the extracted ion 
chromatograms (EIC) at m/z 336.1014 were much reduced than were initially predicted 
by the LC-FLD analysis. It was assumed that ionization may have been suppressed by 
certain compounds eluting at the same retention time, therefore quantification of 11-
oxoTTX and 4-epi-11-oxoTTX were instead carried out using LC-FLD system. The 
limit of detection (LOD) for TTX and its analogues, excluding 11-oxoTTX and 4-epi-
11-oxoTTX from the Solomon Islands samples, was (S/N > 3, 0.01 μg/g), while the 
limit of quantitation (LOQ) was (S/N > 10, 0.03 μg/g). Since 11-oxoTTX and 4-epi-11-
oxoTTX from the Solomon Islands samples were quantified by LC-FLD system, their 
LOD and LOQ were adjusted accordingly and at 0.04 μg/g and 0.14 μg/g, respectively.  
 
Results showed that the major constituents in almost all the skin samples were TTX, 
4,9-anhydroTTX, 5,6,11-trideoxyTTX (with its 4-epi form), 4,4a-anhydro-5,6,11-
trideoxyTTX, and 4,9-anhydro-5,6,11-trideoxyTTX.69) Interestingly, 11-oxoTTX, a rare 
but more potent analogue44,45) with its 4-epi and 4,9-anhydro forms were also observed 
in almost all the A. hispidus and A. nigropunctatus from both Solomon Islands and 
Okinawa, Japan.69) Due to its potent pharmacological effect as revealed by previous 
studies, the detection and quantification of 11-oxoTTX concentration (with more 
accuracy) in toxic pufferfish is much more of an important finding in this study.  
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The HR-ESIMS/MS spectrum of 11-oxoTTX and TTX showed a similar fragmentation 
pattern with characteristic fragment ions detected at m/z 162.0660 (C8H8N3O) and 
178.0614 (C8H8N3O2) which corresponded to the two major fragment ions believed to 
be 2-aminohydroquinazoline and 2-aminodihydroquinazone, respectively42) (Figure 2-
5). Besides the major analogues, few minor analogues such as the monodeoxyTTX (11-
deoxyTTX and 5-deoxyTTX) and dideoxyTTX (5,11-dideoxyTTX and 6,11-
dideoxyTTX) types were also detected. Additional small peaks observed in most of the 
toxic pufferfish from both regions may potentially correspond to other unconfirmed 
minor analogues such as 4,9-anhydro-5,11-dideoxyTTX (m/z 270 eluting at 5 min), 
frequent peak with m/z 270 (eluting at 6.2 min), 4,9-anhydro-5-deoxyTTX (m/z 286 
eluting at 7.7 min) and 4-epi-6,11-dideoxyTTX (m/z 288 eluting at 8.6 min).  
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Figure 2-5. HR-LC-MS/MS spectra of TTX (a) and 11-oxoTTX (b) in the skin of A. 
hispidus No.3 specimen from the Solomon Islands. The sample solution (2 μL) was 
same as shown in Figure 2-4. The predicted structures of the major fragment ions were 
superimposed in the spectra. 
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2-3.1.3 The concentrations of TTX and its analogues in organs of A. hispidus,  
A. nigropunctatus, and D. holocanthus from the Solomon Islands 
 
All of the Solomon Islands specimens were analyzed for the presence of TTX and its 
analogues. This included specimens A. hispidus No.1-3 (Tables 2-8 to 2-11), A. 
nigropunctatus No.1-3 (Tables 2-12 to 2-15), and D. holocanthus No.1-2 (All < LOD, 
and a representative chromatogram can be seen in appendix p.93). TTX and its 
analogues both in the ethanol preserving solutions and in soaked organs were separately 
quantified using HR-LC-MS just after the prepurification procedure. To calculate for 
the overall concentration of TTX and its analogues in each organ, individual 
concentration from the organ was added to the TTX concentration obtained from the 
ethanol preserving solvent which is initially calculated based on the corresponding 
organ weight soaked in each tube. Also of importance in this calculation is the inclusion 
of the 70% recovery rate obtained in charcoal column eluent measured in HR-LC-MS 
and that in the LC-FLD.  
 
The results of individual toxic specimen in Tables 2-8 to 2-10 and 2-12 to 2-14 showed 
that the amount of TTX concentrations vary in both the ethanol preserving solutions and 
the actual organs. For TTX, more content seems to have remained in the organs 
compared to those (TTX) that were naturally extracted and released into the ethanol 
solutions during the storage period. On the contrary, in analogues like 5,6,11-
trideoxyTTX and 4,9-anhydro-5,6,11-trideoxyTTX, their levels seemed to be higher in 
the ethanol preserving solutions than in the actual organs of some specimens (See 
appendix p.92). Probably organ texture in relation to the compounds’ structures may 
contribute to the rate of toxin release during the storage condition.  
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Based on the result in the TTXs concentration tables, it is evident that TTX, 5,6,11-
trideoxyTTX, 4,4a-anhydro-5,6,11-trideoxyTTX, and 4,9-anhydro-5,6,11-trideoxyTTX 
were the most abundant analogues in all organs of the toxic Solomon Islands pufferfish 
species.69) Other minor analogues were also present but in a relatively lower content. 
Besides TTX, of much importance to risks of food poisoning in the Solomon Islands is 
the confirmed presence of potent analogue48,49), 11-oxoTTX which was detected in the 
skin of almost all Solomon Islands toxic specimens.  
 
A general toxin profile also showed that TTX concentrations in the skin were higher in 
all specimens, compared to the relatively lower concentrations in the liver, ovary, testis, 
stomach, and intestine. As seen from the tables of collective data, Tables 2-11 and 2-15, 
the highest TTX concentrations in the skin of A. hispidus and A. nigropunctatus were 
51.0 and 28.7 μg/g, respectively. Moreover, the study also confirmed that TTXs in skin, 
liver, gonad, stomach, intestine, and flesh of the two specimens (a male and a female) of 
D. holocanthus from the Solomon Islands were less than the limit of detection: LOD; 
S/N > 3, 0.01 μg/g. (See appendix p.93). 
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Table 2-8. TTX and its analogues (μg/g) in the organs of A. hispidus No.1 from 
the Solomon Islands. 
Table 2-9. TTX and its analogues (μg/g) in the organs of A. hispidus No.2 from 
the Solomon Islands. 
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Table 2-11. Collective data of TTX and its analogues (μg/g) in the organs of 
A. hispidus from the Solomon Islands. 
Table 2-10. TTX and its analogues (μg/g) in the organs of A. hispidus No.3 from the 
Solomon Islands. 
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Table 2-12. TTX and its analogues (μg/g) in the organs of A. nigropanctatus No.1 
from the Solomon Islands. 
Table 2-13. TTX and its analogues (μg/g) in the organs of A. nigropanctatus No.2 
from the Solomon Islands. 
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Table 2-15. Collective data of TTX and its analogues (μg/g) in the organs of 
A. nigropunctatus from the Solomon Islands. 
For 11-oxoTTX and 4-epi-11-oxoTTX: LOD = 0.04 μg/g (S/N > 3), LOQ = 0.14 μg/g (S/N > 10), for 
other analogues: LOD = 0.01 μg/g (S/N > 3), LOQ = 0.03 μg/g (S/N > 10). 5,6,11-TrideoxyTTX was 
measured as the mixture with its 4-epi form 
Table 2-14. TTX and its analogues (μg/g) in the organs of A. nigropanctatus No.3 
from the Solomon Islands. 
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2-3.2 The concentrations of TTX and its analogues in organs of A. hispidus and  
A. nigropunctatus from Okinawa, Japan 
 
To compare the same pufferfish species from both the Solomon Islands waters and 
Okinawa, Japan, similar organs from three specimens of A. hispidus and four specimens 
of A. nigropunctatus were extracted, pre-purified with activated charcoal, and analyzed 
using HR-LC-MS. Results are shown in Tables 2-16 through to 2-24. As a general 
comparison, almost all toxins analysed in these Arothron species displayed distribution 
profile similar to those from the Solomon Islands. Just like the Solomon Islands toxic 
specimens, skin also contained higher levels of TTX although concentrations varied 
markedly. For instance, A. nigropunctatus No.2 from Okinawa showed a significantly 
higher level (highest in all tested specimens) of TTX and 11-oxoTTX in the skin at 255 
and 42.4 μg/g, respectively compared to the lowest TTX concentration, A. hispidus No. 
1 (TTX - 4.26 μg/g) and A. hispidus No.3 (11-oxoTTX - 0.07 μg/g) all from the same 
region. Similarly, other organs such as stomach also showed higher level of TTX 
concentration (25.5 μg/g) compared to other organs such as liver or gonads which were 
known to accumulate TTX in other pufferfish species.45) 11-OxoTTX with its epi and 
anhydro forms were also detected in the skin of most Okinawan specimens.69) 
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Table 2-16. TTX and its analogues (μg/g) in the organs of A. hispidus No.1 
from Okinawa, Japan. 
Table 2-17. TTX and its analogues (μg/g) in the organs of A. hispidus No.2 
from Okinawa, Japan. 
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Table 2-19. Collective data of TTX and its analogues (μg/g) in the organs of 
A. hispidus No.1 from Okinawa, Japan. 
For 11-oxoTTX, 4-epi-11-oxoTTX and 4,9-anhyydro-11-oxoTTX: LOD = 0.04 μg/g (S/N > 3), 
LOQ = 0.14 μg/g (S/N > 10), for other analogues: LOD = 0.01 μg/g (S/N > 3), LOQ = 0.03 μg/g 
(S/N > 10). 5,6,11-TrideoxyTTX was measured as the mixture with its 4-epi form 
Table 2-18. TTX and its analogues (μg/g) in the organs of A. hispidus No.3 
from Okinawa, Japan. 
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-20. TTX and its analogues (μg/g) in the organs of A. nigropunctatus 
No.1 from Okinawa, Japan. 
Table 2-21. TTX and its analogues (μg/g) in the organs of A. nigropunctatus 
No.2 from Okinawa, Japan. 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-22. TTX and its analogues (μg/g) in the organs of A. nigropunctatus 
No.3 from Okinawa, Japan. 
Table 2-23. TTX and its analogues (μg/g) in the organs of A. nigropunctatus 
No.4 from Okinawa, Japan. 
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Table 2-24. Collective data of TTX and its analogues (μg/g) in the organs of 
A. nigropunctatus from Okinawa, Japan. 
For 11-oxoTTX, 4-epi-11-oxoTTX and 4,9-anhyydro-11-oxoTTX: LOD = 0.04 μg/g (S/N > 3), 
LOQ = 0.14 μg/g (S/N > 10), for other analogues: LOD = 0.01 μg/g (S/N > 3), LOQ = 0.03 μg/g 
(S/N > 10). 5,6,11-TrideoxyTTX was measured as the mixture with its 4-epi form 
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2-3.3 TTXs distribution profile in A. hispidus and A. nigropunctatus from the 
Solomon Islands and Okinawa, Japan 
 
Figures 2-6 to 2-12 displayed the TTX distribution profiles of all the toxic pufferfish 
been investigated in this study as well as the TTXs profile of pufferfish Takifugu 
pardalis from previous study.45) A general comparison of the average TTX 
concentrations in Arothron specimens from the Solomon Islands and Okinawa, Japan 
(Figure 2-10 and 2-11) revealed a marked variation in the TTX accumulated in the skin. 
Results showed that Solomon Islands A. hispidus contained more TTX than the A. 
hispidus from Okinawa, Japan, while the skin of A. nigropunctatus from Okinawa, 
Japan, accumulated more TTX than the same species from the Solomon Islands.69) This 
highlights the fact that although Arothron species accumulates more TTX in the skin, 
the overall TTX content in the skin or other organs of an individual species depends on 
each individual species. 
 
Likewise, a significant difference was also observed in the profiles of Arothron species 
from Solomon Islands and Okinawa (which are tropical regions) with that of the T. 
pardalis collected off the coast of Miyagi Prefecture, Japan, situated in a more 
temperate region. The consistency displayed by high TTX accumulation in the skin of 
Arothron species from the tropical region proved to be very different when compared to 
the higher accumulation of TTX in the reproductive organ and liver of T. pardalis 
collected in the temperate region (Figure 2-12).  Although a large number of data 
focusing on size, gender, breeding seasons or the ecological environment these 
pufferfish strive in may be needed for a valid conclusion, the present study highlights an 
important finding that may address the relationship between TTX profiles and pufferfish 
species collected in at least two different regions. Moreover, this comparison shows that 
the role of TTXs in these species may be more complex than the obvious and speculated 
role as part of the organisms’ defense strategy.  
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Figure 2-6. Average TTX distribution profile of A. hispidus (No.1-3) from 
Solomon Islands. 
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Figure 2-7. Average TTX distribution profile of A. nigropunctatus (sample No.1-3) 
from Solomon Islands. 
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Figure 2-8. Average TTX distribution profile of A. hispidus (sample No.1-3) from 
Okinawa, Japan. 
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Figure 2-9. Average TTX distribution profile of A. nigropunctatus (sample No.1-3) from 
Okinawa, Japan. 
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Figure 2-10. A comparison of the average TTX distribution profile of A. hispidus 
(sample No.1-3) from the Solomon Islands and A. hispidus (sample No.1-3) from 
Okinawa, Japan. 
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Figure 2-11. A comparison of the average TTX distribution profile of A. nigropunctatus 
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Okinawa, Japan. 
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Figure 2-12. TTX distribution profile of T. pardalis collected off the coast of 
Miyagi Prefecture, Japan.45) 
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2-3.4 TTXs distribution profile in the skin of Solomon Islands pufferfish samples. 
 
As previously mentioned, the distribution of TTXs in all toxic Arothron species varied 
among each species and their respective organs, with the highest TTX accumulation 
detected in the skin. However, the extent of TTXs distribution in each skin also showed 
different toxic profiles. As seen in Figure 2-13, the TTX concentration in the skin of A. 
hispidus is lower than the less toxic analogues such as 5,6,11 trideoxyTTX and its 
anhydro forms. On the other hand, TTX in the skin of A. nigropunctatus seems to show 
relatively higher levels although the overall quantity of toxins is still much lower.  The 
analysis of the skin of two D. holocanthus specimen showed very low levels of TTX, 
presumably much lower than the limit of detection (LOD) (Figure 2-13). An example of 
the mass chromatograms of the skin of D. holocanthus No.1 is displayed in the 
appendix p.93. 
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Figure 2-13. TTX distribution profile in the skin of A. hispidus (Sample No.1-3) and 
A. nigropunctatus (Sample No.1-3) compared to D. holocanthus (Sample No.1-2). 
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Since the skin of the toxic species showed interesting variations of toxin profiles, an 
investigation was conducted to see if certain areas of the skin accumulate more TTX 
than others. Analysis were conducted on A. hispidus No.3 and A. nigropunctatus No.1 
respectively. For A. hispidus No.3, a part of skin samples was obtained from slightly 
darker spotted regions, plain white regions, greyish regions and the thin epidermial 
layer just beneath the skin (skin flesh) and were analyse using HR-LC-MS. The TTXs 
concentrations are presented in Table 2-25 and Figure 2-14. Though the greyish region 
showed a slightly higher TTX level (48 μg/g), all regions seem to show the same toxic 
profiles which suggested that TTXs in the skin of this species are evenly distributed in 
all areas of the skin and that the extent of intoxication in predators or humans 
presumably from skin is not dependent on skin regions but on the ingestion of the 
quantity of skin tissue.   
 
 
Table 2-25. TTX and its analogues (μg/g) in the skin of A. hispidus No.3 
from the Solomon Islands. 
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Figure 2-14. TTX distribution profile of in the skin of A. hispidus No.3 from the 
Solomon Islands. 
46 
 
In the A. nigropunctatus No.1 skin sections, the dorsal regions, underside regions and 
the back regions were evaluated for a possible TTX- specific area of accumulation. 
Results showed that both the underside and back areas contained slightly higher TTX 
level (20 and 20 μg/g respectively) compared to the dorsal area (17 μg/g) (Table 2-26 
and Figure 2-15). However, each analogue from these skin regions seemed to show a 
consistent level of concentration, indicating that all analogues are evenly distributed 
throughout the skin tissue. The 5,6,11-trideoxyTTX and its anhydro forms which are 
often higher in some organs were relatively low in this skin specimen. Whether the 
regional skin texture of A. nigropunctatus species contributed differently to its toxin 
distribution profiles is a matter of further analysis and/or debate, however from this 
results it seems that toxins’ distribution in the skin depends entirely on the individual 
specimen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-26. TTX and its analogues (μg/g) in the skin of 
A. nigropunctatus No.1 from the Solomon Islands. 
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Figure 2-15. TTX distribution profile of in the skin of A. nigropunctatus No.1 
from the Solomon Islands. 
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2-3.5 Investigation of STX and its analogues in A. hispidus and A. nigropunctatus 
from the Solomon Islands and Okinawa, Japan 
 
Since a few pufferfish species usually possess both TTXs and STXs, the current study 
was also extended to investigate possible existence of STX, neoSTX, and dcSTX in the 
ovary and the skin of toxic pufferfish species from both the Solomon Islands and 
Okinawa, Japan, using HR-LC-MS and the conditions in section 2-2.7. The choice of 
organs in this section were based on the fact that ovary was previously known to 
accumulate STXs61) and skin in this study possess a markedly higher level of TTX 
whereby their toxin tolerance state may also accumulate STX compounds. The results 
of this study are shown in Tables 2-27 to 2.30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-27. STX analysis of the skin from the Solomon Islands pufferfish.  
 
Table 2-28. TTX analysis of the ovary from the Solomon Islands pufferfish.  
  
 
LOD (S/N > 3) and LOQ (S/N > 10) for STX were 0.02 μg/g and 0.07 μg/g, neoSTX, 0.05 μg/g 
and 0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, respectively.  
LOD (S/N > 3) and LOQ (S/N > 10) for STX were 0.02 μg/g and 0.07 μg/g, neoSTX, 0.05 μg/g 
and 0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, respectively.  
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STX analysis revealed that the STXs concentration in the skin and ovary of all toxic 
pufferfish from the Solomon Islands and the four specimens of A. nigropunctatus from 
Okinawa, Japan were below the LOD (0.02 μg/g). However, the skin of all A. hispidus 
from Okinawa contained STX (0.09, 2.80, 0.34 μg/g) including the ovary of one 
specimen. Interestingly, the highest STXs level obtained in the skin (STX - 2.8 μg/g) 
and (dcSTX - 0.66 μg/g) and ovary (STX - 0.04 μg/g: between LOD and LOQ) in this 
study were from A. hispidus No.2 of Okinawa, Japan. In other samples, dcSTX and 
neoSTX were not detected. LOD (S/N > 3) and LOQ (S/N > 10) for STX were 0.02 μg/g 
and 0.07 μg/g, neoSTX, 0.05 μg/g and 0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, 
respectively.  
 
 
  
LOD (S/N > 3) and LOQ (S/N > 10) for STX were 0.02 μg/g and 0.07 μg/g, neoSTX, 0.05 μg/g and 
0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, respectively.  
LOD (S/N > 3) and LOQ (S/N > 10) for STX were 0.02 μg/g and 0.07 μg/g, neoSTX, 0.05 μg/g and 
0.18 μg/g, and dcSTX, 0.07 μg/g and 0.25 μg/g, respectively.  
Table 2-29. STX analysis of the skin from the Okinawan pufferfish.  
 
Table 2-30. TTX analysis of the ovary from the Okinawan pufferfish.  
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2-4.0 Discussion 
In this study, the analysis of TTX and its analogues in the pufferfish, A. hispidus and A. 
nigropunctatus, from the Solomon Islands and Okinawa, Japan were carried out using 
LC-FLD and HR-LC-MS. Preliminary analysis of the condition of TTX in all organs 
from Solomon Islands specimens by LC-FLD showed that tetrodonic acid peaks were 
approximately 60% of the TTX peaks indicating a partial decomposition in the TTX 
compounds. It should be noted herein that the amount of TTX in the samples from the 
Solomon Islands toxic pufferfish as outline in Tables 2-8 to 2-15 could be 
underestimated due to storage methods, duration and possibly chemical transformation 
of TTX and its analogues.  However, we believe that the data obtained in this study 
holds much valuable information and facts to warn of the high toxicity in these toxic 
pufferfish species from the Solomon Islands.  
 
Due to the chemical properties of TTX in nature such as its solubility to water and heat 
resistance, consumption of pufferfish even after being properly cooked can still cause 
one to suffer from pufferfish intoxication. In areas where cautionary information or 
research facilities are not available, the only way to avoid being intoxicated from such 
toxic animals has been to have the knowledge passed down through generations based 
on previous experiences. In most cases, this is not so reliable considering the 
unregulated introduction of new species into the local environment, existence of 
potentially merging species types, unpredictable distribution of TTX producers and for 
less fortunate societies the potential socioeconomic issues relating to food availability. 
Therefore, screening of TTXs in pufferfish through scientific methods and informing 
people of its proof of existence is thus far the most effective way to reduce risks of 
pufferfish poisoning. 
 
 In this study, not all the flesh from the Solomon Islands toxic specimens were analysed 
due to limited number of storage tubes and volume of ethanol solution available during 
pufferfish collection. For the one specimen of A. hispidus which was analysed, result 
showed that TTX concentration was 0.07 μg/g which is relatively low compared to 
other organs. (See appendix p.92). On the other hand, all the flesh of Okinawan toxic 
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specimens contained TTX concentrations of somewhat lower to much higher levels, the 
highest levels being from A. nigropunctatus No.2 and 4 with concentrations 4.26 μg/g 
and 2.05 μg/g respectively.  
 
Since all species from both the tropical regions are the same and both displayed similar 
toxin profiles, the chances that other flesh from Solomon Islands Arothron species 
would be toxic if analyzed, is highly possible. Previous mouse bioassay studies by 
Khora S, et al.47) and Teruya N, et al.73) also revealed that flesh in Arothron species 
from Okinawa, Japan contained higher levels of toxicity. Since flesh is the tissue that 
usually owes much to most intoxication, the confirmed detection of TTX in Arothron 
species from the Solomon Islands and Okinawa, Japan should call for a ban on the 
consumption of these species from both regions.    
 
TTX analysis of A. hispidus and A. nigropunctatus from the Solomon Islands and 
Okinawa, Japan, consistently revealed that skin accumulates more TTX than any other 
organs.69) The highest level of TTX concentration obtained in this study was from the 
skin of A. nigropunctatus No.2 from Okinawa, Japan, at 255 μg/g with the lowest being 
from A. hispidus No.1 also from Okinawa at 4.26 μg/g. The highest TTX concentration 
in the skin of Solomon Islands toxic specimens is from A. hispidus No.1 at 51.0 μg/g 
while A. nigropunctatus No.2 contains lower TTX level at 7.20 μg/g. From this data, it 
is evident that TTX composition in the skin tissue is highly variable among pufferfish 
species.  
 
Separate studies on A. nigropunctatus collected in the Philippines and Okinawan, Japan 
also confirmed comparable levels of TTX in the skin tissue 47,74). An investigation of 
Hawaiian A. hispidus suggested high levels of TTX producing bacteria were isolated 
from the skin.75) Studies on Kytoccocus sedentarius bacteria believed to be a TTX-
producer isolated from the skin of A. hispidus also displayed modulating activities 
against P388 cell lines.76) Other pufferfish species from Arothron genus which have 
shown to contain a considerable level of TTX either in their skin or in other organs are 
A. immaculatus.77) A. firmamentum78) A. meleagris,78) A. reticularis79) and A. stellatus.52) 
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The very high level of TTX concentration in the skin has prompted the need to 
investigate the potential distribution of TTXs in the skin tissue. Exemplary analysis was 
carried out in different skin regions of A. hispidus No.3 and A. nigropunctatus No.1 
from the Solomon Islands (Tables 2-25 and 2-26). The TTX analysis of the slightly 
darker spotted regions, plain white regions, greyish regions and the thin epidermal layer 
just beneath the skin (skin flesh) of A. hispidus No.3 showed a TTX concentration range 
of 40-48 μg/g (Table 2-25) which was assumed to be an even distribution of TTXs 
throughout the regions of the skin tissue.  On the other hand, A. nigropunctatus No.1 
showed a TTX concentrations of 17 μg/g, (dorsal regions), 20 μg/g (underside regions) 
and 20 μg/g (back regions) (Table 2-26). As a matter of physical observation, smooth 
and glossy skin textures are distinctively observed around the dorsal region while a 
rough texture with few small spikes uniformly covers the other regions from the base of 
the dorsal end, throughout the mid-body and reaches the base of the tail and fins. 
Whether these skin textures or their function play a role in TTX accumulation levels is 
yet to be fully confirmed due to limited samples used in the analysis of this species.  
Moreover, since different species contains different TTX profiles, speculative 
assumptions based on a single specimen cannot be used to fully verify the exact TTX 
accumulation in each species. However, despite the slight variation of TTX content, the 
profile of all the other analogues in these areas showed a similar pattern which 
seemingly accounts for an equal distribution of these analogues which at this point 
would also include the TTX.  
When comparing the TTX distribution in this study to the Japanese pufferfish T. 
pardalis, a significant difference can be observed (Figure 2-12). T. pardalis contains 
higher levels of TTX in the liver and gonads,80) but in Arothron species, these organs 
have a much lower TTX compared to the skin. From this study, it is highly possible that 
different regions together with their different biotic and abiotic factors, may play a 
leading role in the TTX accumulation ability of the various dominant pufferfish species 
in each region. Moreover, few important factors that may contribute a lot to the 
difference in TTX accumulation and distribution are the size of individual specimen, 
gender, breeding seasons and the immediate ecological interaction faced by each 
pufferfish species in their environment. 
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On a molecular level, proteins which are implicated in the TTX accumulation system 
may contribute to variations in toxins profile among species. Studies showed that these 
glycoproteins, named as PSTBP (puffer fish saxitoxin and tetrodotoxin binding protein), 
bind to TTX and STX in the blood plasma of Takifugu pardalis.81-83) Though parallel 
PSTBP screening studies should also be done for the blood plasma of Arothron species, 
the underlying question of how pufferfish directs TTX accumulation to specific organs 
is an interesting study with potential application in biomolecular sciences and 
toxicology. Moreover, to properly verify the TTX distribution profile in pufferfish 
species from the tropical regions, more specimen collections and analysis are required. 
 
Other analogues with significant concentrations in this study were the 4,9-anhydroTTX, 
5,6,11-trideoxyTTX, 4,4a-anhydro-5,6,11-trideoxyTTX and 4,9-anhydro-5,6,11-
trideoxyTTX. Due to the structural proximity of TTX and 4,9-anhydroTTX, it is highly 
possible that chemical equilibrium between the two may have resulted in its higher 
concentration.60,80) An analogue that frequently surpass the TTX concentration in few 
organs is the 4,9-anhydro-5,6,11-trideoxyTTX (Tables 2-11, 2-19 and 2-24).  
Analogue 5,6,11-trideoxyTTX on the other, proves to be a major analogue not only in 
this study but in many pufferfish species including Japanese T. pardalis,80)  
T. Oblongus,84) T. nigroviridis,85) Lagocephalus sceleratus,86) Fugu poecilonotos 87) and 
gastropod such as Charonia lampas88) and Nassarius spp.89) Previous experiment 
showed that 5,6,11-trideoxyTTX has a relatively low toxicity (LD99 720 μg/kg, mice, 
i.p.)46) compared to TTX and other toxic analogues. 
 
As previously highlighted, 11-oxoTTX a rare but very potent analogue was detected in 
A. nigropunctatus and A. hispidus from the Solomon Islands and Okinawa, Japan 
(Tables 2-11, 2-15,2-19 and 2-24). Studies by Yotsu-Yamashita M, et al.49) on the TTXs 
structural affinity to rat brain membrane showed that C-6 and C-11 are hydrogen bond 
donors and are vital in binding toxins to sodium channels. Since 11-oxoTTX contains 
an additional OH group in C11, probably its binding affinity to sodium channels is more 
high and efficient than TTX thus increasing its potency. Since the first isolation of 11-
oxoTTX from a Micronesian A. nigropunctatus,47) few other occurrences were detected 
in Brazilian frog,90) the red spotted newt,91) the blue-ringed octopus,92) the marine 
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snail93) and the xanthid crab.94) The detection of 11-oxoTTX in A. hispidus from 
Solomon Islands is the first to be recorded in this species. Due to the higher potency of 
11-oxoTTX (4-5 times potent than TTX) as revealed by some authors,48,49) its presence 
in A. hispidus and A. nigropunctatus are indeed a potential risk to pufferfish poisoning.  
 
Analysis of two specimen of D. holocanthus from Solomon Islands showed no TTX 
level or a negligible level of TTX concentration at LOD 0.01 μg/g (S/N > 3) (appendix 
p.93). Whether there are physio-ecological reasons for such results, it is not confirmed. 
However, when comparing the physical appearance of D. holocanthus to the Arothron 
species, it is evident that the skin textures of each species type varies significantly. D. 
holocanthus consists of a rough, rugged spiky-like skin texture while Arothron species 
are composed of few coarse but fairly smooth skin texture. Theoretically, if TTX is 
really a part of their defense strategy to void off predators than for ecological reasons it 
is likely that Arothron species would need to accumulated more TTX to protect itself 
whereas for D. holocanthus, it has adapted a more obvious method of defense.  
 
Moreover, results displaying low or no TTX level in D. holocanthus may also support 
the very reason why some genus of Diodon species are a part of food source in some 
regions. According to the Ministry of Health, Labour and Welfare of Japan, the skin, 
flesh, and testis of D. holocanthus collected in Japan region are officially allowed for 
consumption.63) Nevertheless, since the producers of TTX in marine environment such 
as Vibrio spp.95) Aeromonas spp.96) Pseudomonas spp.97) cannot be tracked instantly and 
along with fewer to no analytical toxicology research on genus of Diodon species in the 
Solomon Islands, a possibility that intoxication from D. holocanthus cannot affect 
potential consumers in Solomon Islands or other nearby tropical regions cannot be 
totally ruled out. The negligible presence of TTXs (below LOD) observed in this study, 
needs to be supported by additional investigation of few more D. holocanthus from 
other areas of the Solomon Islands and in nearby regions to verify the status of TTX in 
this species. 
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The presence of STX and its analogues were also tested in the skin and ovary of A. 
hispidus and A. nigropunctatus from the Solomon Islands and Okinawa, Japan. STX 
was detected in the skin of all three specimens of A. hispidus from Okinawa (0.09, 2.80, 
0.34 μg/g), as well as in the ovary of one specimen, but not detected in all A. 
nigropunctatus from Okinawa and all the pufferfish specimens from the Solomon 
Islands (< 0.02 μg/g). It is notable that the concentration of STX equivalents (STX + 
dcSTX) was 3.46 μg/g in the skin of an A. hispidus specimen from Okinawa.69) This is 
higher than the global regulatory limit of 800 μg of STX equivalents per kg of shellfish 
meat (e.g. Codex, EU, US, Japan).98-101) Additional analysis of STX in more specimens 
from both regions should be conducted because Nakashima K, et al.61) also reported that 
STX and dcSTX were detected in the ovary of A. firmamentum collected in Japan at 
high concentration. I hope the results obtained in this present study will help inform the 
citizens of Solomon Islands of the potential risks associated with the consumption of the 
toxic pufferfish species living within their coastal waters. 
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2-5.0 Conclusion 
The present study showed that both A. hispidus and A. nigropunctatus specimens from 
the Solomon Islands and Okinawa, Japan, accumulated higher level of TTX and its 
analogues in the skin compared to other organs such as liver, ovary, testis, stomach, 
intestine, and flesh. Due to the high TTX concentration in the skin of these two species 
from the Solomon Islands (51.0 and 28.7 μg/g at highest) and Okinawa, Japan (12.7 and 
255 μg/g at highest), a ban on their consumption should be imposed by relevant 
authorities. In addition, the presence of 11-OxoTTX, a rare but more potent analogue 
than TTX commonly detected in all toxic specimens in this study should also warn 
citizens of these regions of the potential risks of higher toxicity. STX was detected in 
the skin of all A. hispidus specimens from Okinawa, Japan, with one of the specimen 
showed presence of STX in the ovary. The level of STX equivalents (STX + dcSTX) in 
the skin of one specimen was 3.46 μg/g, which is more than the global regulation level. 
More monitoring and awareness programs as well as up-to-date toxicity studies of 
pufferfish species (including other Arothron species) and other marine natural biotoxins 
is recommended for these regions. 
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Chapter 3.0 Studies on Marine Invertebrates  
Introduction of Marine Natural Products. 
Natural products are intriguing sources of bioactive secondary metabolites. It was 
estimated that approximately 75% of antibiotic and anticancer drugs currently in use are 
from natural sources or are at some point derived or modified from natural product 
compounds.102) Marine environment has been a source of knowledge for centuries. With 
the need to survive these competitively harsh conditions, marine organisms are believed 
to have developed predative and/or defensive mechanisms to hunt or protect themselves 
and in doing so produce some of the most interesting secondary metabolites useful in 
combating a variety of diseases. Marine invertebrates such as marine sponges, soft and 
hard corals, tunicates or even marine microbes and fungi are few examples. Marine 
sponge in particular, has been extensively studied for the purpose of drug discovery and 
biomedicine.103,104) In this study, marine sponges collected in the Solomon Islands were 
screened for potential bioactive compounds using bioassay guided fractionation method. 
Cell-based bioassay was employed as the basis for each stages of fractionation.  
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Chapter 3.1.0 Minor Introduction (Melophlus sp.) 
Steroidal glycosides such as the 30-norlanostane triterpenoidal saponin sarasinosides 
from marine sponges (class Demospongiae)105) contain variable congeners106-108) that 
possess various biological activities against bacteria, yeast, or fungi,109,110) 
ichthyotoxicity against killifish Poecilia reticulata 110), and cytotoxicity against cancer 
cell lines.111-114)  
Since the first isolation of a sarasinoside from the Palauan marine sponge Asteropus 
sarasinosum by Kitagawa and group,110) continuous discovery by various groups have 
so far been made on the marine sponge genus Melophlus.109,111-114) Generally, known 
sarasinosides are classified according to their aglycon skeleton structures and sugar 
moieties which are represented by either pentaoside or tetraoside sugar types109,114) 
(Figure 3-1).  
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1. Few known sarasinosides categorized on the basis of their steroidal 
structures and sugar moieties. 
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In this study, the discovery of a new sarasinoside congener, sarasinoside M2 (1; Figure 
3-2), will be discussed along with known sarasinosides B1 (2) and B2 (3) or B3 (4) 
(Figure 3-3), which were isolated from a marine sponge assumed to be Melophlus sp. 
collected in the Solomon Islands (Figure 3-4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2. Structure of sarasinoside M2 (1)                                                                                                                                        
Figure 3-3. Structures of sarasinoside B1-3 (2-4)                                                                                                                                        
2. ∆8(9)     sarasinoside B1  
3. ∆7,9(11)  sarasinoside B2 
4. ∆8(9),14  sarasinoside B3    
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3-2.0 Procedure 115) 
 
3-2.1 Isolation and purification 
 
A marine sponge identified via the database to have shown the identical physical 
features of a Melophlus sp. (Figure 3-4) was collected in the Solomon Islands, cut into a 
small portion that weighed approximately 7.0 g and was transported to Tohoku 
University in a disposable plastic tube (TPP, Trasadingen, Switzerland) containing 20 
mL of the EtOH–H2O mixture (7:3, v/v) at room temperature. Upon arrival, the 
specimen was kept in -25ºC until use.  
 
The specimen was chopped, minced, soaked in 20 mL of EtOH–H2O (9:1, v/v) and left 
to macerate for a while. After the supernatant was remove this procedure was repeated 
two more times and together with the preserving solvent [EtOH–H2O (7:3, v/v)], the 
mixture was filtered through ADVANTEC Toyo filter No.2 - 185 mm (Toyo Roshi 
Kaisha, Ltd., Tokyo, Japan) and vacuum dried using rotary evaporator.  
 
 
 
Figure 3-4. Melophlus sp. collected in the Solomon Islands. 
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The extract was then partitioned between ethyl acetate (EtOAc) and H2O (2:1, v/v). The 
dried residue (40 mg) from the EtOAc portion was suspended in 100 μL of MeOH, 
which was then applied to a Sep-Pak® C-18 SPE cartridge (0.7 mL, Waters, USA) to 
obtain six fractions [MeOH–H2O: 0:1, 3:7, 1:1, 8:2, 1:0 (v/v), and absolute acetonitrile] 
(F1-6). Scheme 3-1) Based on the preliminary cell-base assay from mouse 
neuroblastoma 2a cell line with a concentration of 100 ug/mL, the fractions MeOH–
H2O (8:2/1:0) showed a high cytotoxicity (Figure 3-5) which was the focus of the next 
stage of purification procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Scheme 3-1. General extraction procedure and Sep Pak fractionation method.                                                                                                                  
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3-2.2 Cytotoxicity bioassay 
 
Compounds 1 and 2 were tested for their toxicity against mouse neuroblastoma (Neuro-
2a) and human hepatocyte carcinoma (HepG2) cell lines. The cells were cultured in 
RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% 
fetal bovine serum and 100 μg/mL streptomycin and 100 U/mL penicillin in 96-well 
plates and incubated at 37 °C in 5.0% of CO2 /air. The test compounds were solubilized 
in DMSO and were added to the cells (DMSO final conc. 0.50%, v/v) after a 
preincubation of 12 h. After a 24 h, Cell Count Reagent SF (Nacalai Tesque) was 
added, and the cells were re-incubated for 2.5 h. Rotenone was used as the positive 
control, while a separate 0.5% v/v DMSO was the negative control. The cytotoxicity 
was evaluated by means of absorbance at 405 nm on a Bio-Rad 680 Microplate reader. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 3-5. Preliminary cytotoxicity result after the Sep Pak 
fractionation of Melophlus sp.                                                                                                             
Scheme. 3-2. Flow diagram of cytotoxicity bioassay.                                                                                                                  
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3-2.2 HPLC Purification 
The residues from the MeOH–H2O (8:2/1:0) fractions were combined (5.4 mg) and was 
then subjected to a Mightysil RP-18GP II column chromatography (10 × 250 mm, 5 μm, 
Kanto Chemical, Tokyo, Japan) with a condition set as stepwise elution: MeOH–H2O 
1:1, 8:2, 9:1, and 1:0 (v/v). The parameter for UV detection was set at 240 nm and was 
observe using a diode array detector (DAD) (Hitachi Chromaster 5430, Hitachi, Japan) 
(Figure 3-6) 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
The screening of compounds in fractions correlating the peaks observed in the UV-
DAD were first performed using API 2000 AB SCIEX.  From each fraction 2 μL was 
diluted tenfold and 5 μL was injected into the API 2000 AB SCIEX by direct injection. 
General parameters were set as a positive mode, 2 min run time with a target range of 
m/z 400 – 1500. This gave the specific candidate compounds which ultimately helped 
narrowed the focus of the search.  To further verify the candidate compounds, 2 μL 
from each fraction was diluted one hundred-fold and 1 μL (1-2 ng) of each fraction was 
applied to the high-resolution (HR) electrospray mass spectrometry (ESI-MS; 
MicrOTOF QII, Bruker Daltonics, Billerica, MA, USA).  
 
 
Figure 3-6.  LC-DAD chromatogram of Sep Pak fraction (F4-5).   
A) Mixture of C and D. B) is the new sarasinoside M2, C) is sarasinoside 
B2 or B3, D) is sarasinoside B1                                                                                                               
Column: Mighysil RP-18 GPII 250 mm, (5 μm). Kanto Chemical) 
Mobile Phase: A: MeOH, B: H
2
O. Initial 50% A, 80% A, 90% A, 
100% A (0-100 min). 1.0 mL/min 
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The screening result led to the identification of the new sarasinoside congener 
(sarasinoside M2, (1), along with other known sarasinosides B1 (2)
110 and B2 (3) or B3 
(4). The weight of 1 was approximately 0.8 mg, 2 approximately 1.4 mg while 3 or 4 
was at least 1.0 mg. The fraction containing the new sarasinoside was further purified 
using a Cosmosil Cholester column (4.6 × 250 mm, 5 μm, Nacalai Tesque, Kyoto, 
Japan), with gradient elution of MeOH–H2O (8:2, v/v) : MeOH–formic acid (99.9:0.1, 
v/v). Figure 3-7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3-7. LC-DAD after further purification of the fraction containing the new 
compound; sarasinoside M2 (1).                                                                                                            
Cholester (Cosmosil) (4.6 x 250 mm. Nacalai tesque) 
Gradient Elution; MeOH–H
2
O (8:2, v/v): MeOH–formic acid 
(99.9:0.1 v/v), (100 min), 0.5 mL/min 
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3-2.2 LC-MS Analysis by API 2000 SCIEX TM 
Prior to drying the new compound, 2 μL of the fraction containing the new compound 
was diluted tenfold and was analysed using the API 2000 AB SCIEX LC-MS to check 
for its purity. The Cosmosil Cholester column (4.6 × 250 mm, 5 μm, Nacalai Tesque, 
Kyoto, Japan) was used on a positive selected ion monitoring (SIM) mode, with a 
mixture of MeOH-H2O (8:2) v/v and a flow rate of 2 mL/min at a duration of 95 min 
(Figure 3-8). The major (SIM) ion chromatogram was set at m/z 1295 along with other 
additional minor target ions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SIM chromatogram displayed a single peak at approximately 80 min which indicated 
that the compound was at least much closer to pure. The fraction containing the new 
sarasinoside was dried to an extent where a colorless powder was obtained, weighed 
(approximately 0.5 mg) and suspended in CD3OD (0.4 mL) for NMR spectral analysis.  
The new sarasinoside was named sarasinoside M2 which is a congener of the 
sarasinoside group of compounds. 
 
  
Figure 3-8. SIM chromatogram of a more purified form of the new sarasinoside 
M2 (1)                                                                                                             
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3-3.0 Results/Discussion 
 
3-3.1 Structure Determination 
 
From the HR-ESI-MS peak spectrum of 1, its molecular formula was determined to be 
C61H96N2O26 and showed [M + Na]
+ m/z 1295.6128 (calcd. for C61H96N2O26Na 
1295.6144; and [M + H]+ m/z 1273.6305 (calcd for C61H97N2O26 1273.6309). (Figure 3-
9 (A)). The negative mode also supported the existence of 1 with precursor ions [M – 
H] – m/z 1271.6062, (calcd for C61H97N2O26 1271.6068), [M + Cl]
 – m/z 1307.5846 and 
[M + HCOOH – H] – m/z 1317.6124 (Figure 3-9 (B)). 
   
 
 
 
 
 
 
 
     
 
 
 
 
 
 
Figure 3-9.   HR-ESI-MS spectrum of 1 in both A) positive and B) negative 
ion modes.                                           
B                                                                                                       A                                                                                                        
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Partial assignment of the 1H NMR (Figure 3-10) signals and 13C NMR signals of 1 were 
performed on the basis of gradient COSY, TOCSY, TOCSY1D, and gradient HSQC 
spectra as shown in the appendix p.94-98, 104-109.  
 
The assignment of the 1H NMR signals and 13C NMR signals are listed in Table 3-1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-1. NMR spectroscopic data of sarasinoside M2 (1) in CD3OD.  
                                                                                                                   
1H NMR (600 MHz), 13C NMR (151 MHz). ND represents “not determined”. *interchangeable assignment.                                                                                                                                    
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Compound 2 was identified using HR-ESI-MS at [M + Na]+ m/z 1281.6310, calcd. for 
C61H98N2O25Na 1281.6351, and [M + H]
+ m/z 1259.6498   calcd for C61H99N2O25 
1259.6531 (Figure 3-11 (A)). The negative mode also supported the likely presence of 2 
by displaying precursor ions [M – H]– m/z 1257.6058, [M + Cl] – m/z 1293.6183 and [M 
+ HCOOH – H] – m/z 1303.6105 (Figure 3-11 (B)). SciFinder database search and 
spectral comparison from NMR data in literature showed that 2 corresponded to a 
known sarasinoside B1 which was first isolated by Kobayashi and Kitagawa 
group.110,114) The 1H NMR signals and 13C NMR signals assignment of 2 which 
resembled the literature value are listed in Table 3-2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-10. 1H NMR spectrum of 1 with major signals of structural assignment.                                                                                                                                     
Figure 3-11. HR-ESI-MS chromatogram of 2 in both A) positive and B) 
negative ion modes. 
                                                                                                                 
 
Figure 3-10.   HR-ESI-MS chromatogram of 1 in both positive (A) and 
negative B) mode.                                                                                                          
A                                                                                                        B                                                                     
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Assignment of the 1H NMR signals and 13C NMR signals of 2110) were performed on the 
basis of gradient COSY, TOCSY, TOCSY1D, and gradient HSQC spectra as shown in 
appendix p.99-103, 104-109. This NMR spectral assignment were almost the same as 
the one in the literature110, 114) except that additional signals were detected in 2 from the 
Solomon Islands marine sponge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-2. NMR spectroscopic data of sarasinoside B1 (2) in CD3OD.  
                                                                                                                   
1H NMR (600 MHz), 13C NMR (151 MHz). ND represents ‘not determined”.                                                                                                                                   
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HR-ESI-MS of compounds 3 or 4110,114) revealed [M + H]+ m/z 1257.6373;  calcd for 
C61H97N2O25, 1257.6375, [M + Na]
+ m/z 1279.6205; calcd for C61H96N2O25Na, 
1279.61.94. (Figure 3-12. Both 3 and 4 have the same molecular formula [M + H]+ m/z 
1257.6373 however due to low recovery of this compound, the NMR spectral data 
which would identify the assumed known compound was not obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-12. HR-ESI-MS spectrum of 3 or 4 in a positive ion mode.                                                                                                          
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By comparing the chemical shifts and coupling constants of 1H NMR signals of the 
sugar moiety of 1 and 2, results showed that all values detected were similar for both 
compounds although few coupling constants of the 1H signals of the sugars of 1 were 
not completely determined as can be seen in Table 3-1 and 3-2.  To confirm that 1 and 2 
possess the same sugar moiety, which is a sarasinoside B-type, an additional 
measurement of the TOCSY1D spectra of 1 and 2 were performed. (See appendix 
p.104-109).  The two compounds were irradiated at the anomeric proton signals on each 
of the five sugars and independent H-6 signals of GlcNAc. Result showed a similarities 
between the irradiated targets of 1 and 2, indicating that both possess the same sugar 
moiety. Additional comparison suggested that the sugar moiety of 1 is 3β-O-[β-Glcp 
(1→2) β-Xylp (1→6) β-GlcNAcp (1→2) (β-GalNAcp (1→4)) β-Xylp], which is the 
same as 2110) except that the absolute configuration to verify their stereochemistry was 
not determined.  
 
Similarly, the HR-ESI-MS/MS fragmentation pattern of 1, 2 and 3 or 4 all displayed a 
sarasinoside B type sugar moiety. The HR-ESI-MS/MS spectra of 1, 2 and 3 or 4 were 
recorded by setting the precursor [M + Na]+ ions at m/z 1295.6128, m/z 1281.6178 and 
m/z 1279.6170 respectively. Although each compound has a different molecular weight 
(except for 3 and 4), the fragmented ions that were gradually decomposed were very 
similar and corresponded to the same group of sugars they all possess. For instance, 
HR-ESI-MS/MS peaks of 1 detected at m/z 1295.6128 (calcd. for C61H96N2O26Na 
1295.6130, m/z 1092.5309 (calcd. for C43H83NO21Na 1092.5309) and m/z 798.4380 
(calcd. for C32H65NO12 798.4380) represented the molecule of 1 and its degrading 
fragment ions after a sequential loss of GalNAc, Glc, and Xyl2 sugars respectively. 
Similarly, the lower fragment ions of 1 detected at m/z 498.1826, 336.1306, and 
204.0883 (Figure 3-13 (A)) indicated that Glc-Xyl2-GlcNAc, is also present in the 
molecule of 1 which is apparently the same for 2 and 3 or 4 (Figure 3-13 (B, C)).  
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A) sarasinoside M2 (1) 
B) Sarasinoside B1 (2) 
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C) sarasinoside B2-3 (3-4) 
Figure 3-13. HR-ESI-MS/MS with the fragmented ions of A) 1, B) 2 and C) 3 or 4. 
 Acronyms HN, H, and P represent N-acetyl hexose, hexose, and pentose, respectively.                                                                                                                
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Among other similar structural features that are present in the structures of 1 and 2, 
1HNMR data signals at 6.21 ppm in 1 and 6.22 ppm in 2 corresponding to C24–C26, 27 
(Figure 3-14) along with other signals suggested that both compounds possessed the 
same side chain structure which is a dimethyl substituted enone moiety at carbon 
positions C20–C27. Therefore, the difference between 1 and 2 is likely to be observed 
in their steroidal structures. By comparing their molecular formulas, the similarities in 
their distribution patterns and the side chain structure, it is apparently clear that the 
difference only exist in the molecular formula of the core steroidal structure which 
excluded the side chain at positions C20–C27. The core steroidal structure of 1 is 
proposed to be C21H32O, while that of 2 is C21H34. Moreover, the presence of oxygen in 
1 would account for the additional 18 amu (one oxygen and absent of two hydrogen due 
to ether bond) calculated in the molecular weight of 1.   
1H NMR data comparison of the aglycon of 1 (Table 3-1) with the known sarasinosides 
that also possessed C21H32O as a steroidal structure showed a similarity in the aglycon 
structures of 1 and sarasinoside M (5)115) (Figure 3-15). Both contained a rare ether 
bond between two olefin carbons (C8 and C9). The existence of the ether bond in 1 was 
supported by the presence of the characteristic coupling signals of H-11 (δ 5.21, t 6.4 
Hz) and H2-12 (δ 3.00, dd 13.0, 6.4 Hz; δ 2.12, m) shown in COSY and TOCSY 
spectra of 1 (S3, S4). This is very similar to the coupling signals of 5 at 
 H-11 δ 5.21, t 6.9 Hz and H2-12 δ 3.00, dd, 13.2, 6.9 Hz; δ 2.12, dd, 13.2, 6.9 Hz) as 
described by Dai HF, et al.116) An evidence that showed the natural existence of the 
seemingly unstable C8-C9 ether bond can be seen in the structure of tylopiol A117) 
(Figure 3-16 (A)), along with its crystal structure (Figure 3-16 (B)) and plastic model of 
sarasinoside M2 to show the α-orientation (stereochemistry) of the ether bond at position 
C8-C9 (Figure 3-16 (C)).  
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Due to the limited amount of 1 (0.5 mg), a sufficient 13C NMR cannot be fully assigned. 
However, a coupling correlation in the HMBC spectrum of 1 which proved the presence 
of ether bond in 1 was observed in C9 (δ 171.2)/H3-19. This greatly supported the 
structure of 1 since 5 also displayed a similar chemical shift at position C9 (δ 172.7).115) 
It is worth noting that the difference of the chemical shift between the aglycon of 1 and 
5 was less than 0.1 ppm in the 1H NMR spectrum and less than 1.5 ppm (C9) in the 13C 
NMR spectrum, which supported a structural resemblance in their aglycon. The 
absolute configuration of the aglycon of 1 was not determined due to the limited sample 
obtained. 
 
 
 
 
 
 
 
Figure 3-14. COSY spectrum (CD
3
OD, 600 MHz) of sarasinoside M2 
(1) with the characteristic cross peaks. 
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Therefore, the difference between 1 and 5 would likely to be found only in a sugar 
moiety which would suggest that the internal Glc present in 5 is replaced by Xyl in 1. 
The difference in the hydroxymethyl substituent of 1 and 5 along with the structural 
difference in ether bond between C8-C9 of 1 and double bond in C8-C9 of 2 agrees well 
with each of their molecular formula, molecular weight and other structural features, 
thus, making 1 a new sarasinoside congener. Since 5 contained a sarasinoside A type 
sugar moiety, the presence of Glc of 5 compared to Xyl of 1 (both located in the third 
sugar of the sugar moiety group) categorizes 5 to be a sarasinoside A type compound.  
Other reported steroidal congeners with a characteristic ether bond between two olefin 
carbons included tylopiol A,117) sarasinoside A4,
118) and jereisterol A.119)  
 
 
 
 
 
 
 
 
 
 
 
1: R=H             sarasinoside M
2
 
5: R=CH
2
OH    sarasinoside M 
Figure 3-15. Structures of sarasinoside M2 (1) and M (5).                                                                                                                                       
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A 
B C 
Figure 3-16. A) Stereochemistry of tylopiol A. B) A crystal structure of 
tylopiol A obtained by X-ray analysis. C) A model structure of 
sarasinoside M2 that supports the α-orientation of the ether bond.  
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3-3.2 Cytotoxic Activity Test 
 
Compounds 1 and 2 were tested for their cytotoxic activity using the procedure outlined 
in the methodology section 3-2.2. The IC50 values (half maximal [50%] inhibitory 
concentrations, mean ± SD, n = 3) for 1 and 2 toward Neuro-2a cells were 
approximately 21.5 ± 1.6 and 7.3 ± 0.3 μg/mL respectively (Figure 3-17 (A, C). For the 
cytotoxicity bioassay using HepG2 cells, the incubation period was extended to 48 h 
due to their slow growth rate. The cytotoxic activity against HepG2 cells revealed IC50 
for 1 as approximately 20.4 μg/mL and 26.7 μg/mL with the average IC50 of 24 μg/mL 
(n = 2, due to limited sample amount) and for 2 as 7.4 ± 1.2 μg/mL (mean ± SD, n = 3; 
Figure 3-17 (B, D)). Although the cytotoxicity of 1 and 2 markedly displayed different 
cytotoxic strengths, both compounds are categorized as possessing a moderate activity 
towards Neuro 2a and HepG2 cell lines. These values also correlated the reported 
cytotoxicity of other sarasinosides against K562 leukemia and A549 lung carcinoma 
cell lines.120)  
 
According to Kalinin V, et al.108) the decrease in the biological activities of sarasinoside 
type compounds can be a result of the modifications in C and D rings. These may 
include the migration of double bond into C8(14)-position, the presence of introduced 
oxygen-bearing substituents and various occurrences of oxidative transformations in 
cyclic systems of aglycons. In relation to this study, the difference in the cytotoxic 
activities displayed by 1 and 2 seemed to support the structural changes and their 
biological properties highlighted by Kalinin V, et al.108)  
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Figure 3-17. Cytotoxicity activity of sarasinosides M2 (1) and B1 (2) against Neuro-
2a and HepG2 cell lines. 
A) Cytotoxicity of sarasinoside M
2 
against Neuro-2a cells 
B)  Cytotoxicity of sarasinoside M
2 
against HepG2 liver cells 
Sarasinoside M
2
 displayed IC
50
 at 21.5 ± 1.6 
µg/mL. Cytotoxicity bioassay carried out in 
triplicate (n=3). 
Sarasinoside M
2
 displayed IC
50
 at 24 µg/mL 
(mean of two data). Cytotoxic bioassay carried 
out in duplicate (n=2). 
C)  Cytotoxicity of sarasinoside B
1 
against Neuro-2a cells 
D)  Cytotoxicity of sarasinoside B
1 
against HepG2 liver cells 
Sarasinoside B
1
 displayed IC
50
 at 7.3 ± 0.3 µg/mL.  
Cytotoxicity bioassay carried out in triplicate (n=3). 
Sarasinoside B
1
 displayed IC
50
 at 7.4 ± 1.2 µg/mL.  
Cytotoxicity bioassay carried out in triplicate (n=3). 
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3-3.0 Conclusion 
 
Our chemical studies on Melophlus sp. have isolated a new sarasinoside congener, 
sarasinoside M2 (1) along with other known sarasinosides B1 (2), B2 (3) or B3 (4). The 
HR-LC-MS/MS fragmentation pattern analysis showed that all the isolated compounds 
possessed a sarasinoside B-type sugar moiety. The aglycon structure of 1 was the same 
as the aglycon of sarasinoside M (5), however the difference between 1 and 5 was the 
presence of xylose in 1 as opposed to a glucose in 5 at third sugar position. Biological 
evaluation showed that 1 and 2 displayed moderate cytotoxic activity against both 
Neuro 2a and HepG2 cell lines. 
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Chapter 4.0 Studies on Marine Invertebrates 
4-1.0 Minor Introduction (Haliclona sp.) 
Marine sponge Halichlona sp. belongs to the Order Haplosclerida and family 
Chalinidae.121)
 
Research on various Haliclona species have resulted in the isolation of 
numerous compounds, most of which included the alkaloids, macrolides, steroids, 
peptides and polyketides.122-126) Among many of the bioactive compounds isolated from 
genus Haliclona were antibacterial activities,127) anti-parasitic activities 127) and 
anticancer activities, 128,129). In this section, the isolation studies of a Haliclona sp. 
(Figure 4-1) collected in the Solomon Islands is being discussed. 
 .  
 
 
 
 
 
 
 
 
 
4-2.0 Procedure 
 
4-2.1 Isolation and purification 
A portion (6.0 g) of a marine sponge identified as a Haliclona sp. (Figure 4-1) through a 
marine sponge database was collected in the Solomon Islands, preserved in 20 mL of a 
disposable plastic tube (TPP, Trasadingen, Switzerland) containing 20 mL of the EtOH–
H2O mixture (7:3, v/v) and transport to Tohoku University at room temperature. After 
arrival, the specimen was kept in -25 °C until use. The specimen was minced and 
soaked in the 20 mL of EtOH–H2O (9:1, v/v) and left to macerate for few hours.  
 
 
Figure 4-1. Marine sponge Haliclona sp. collected 
in the Solomon Islands.                                                                                                                
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After the maceration period, the supernatant was collected and the same procedure was 
repeated two more times, after which all the supernatant and the the preserving solvent 
[EtOH–H2O (7:3, v/v)] were combined and filtered through a ADVANTEC Toyo filter 
No.2 - 185 mm (Toyo Roshi Kaisha, Ltd., Tokyo, Japan). The filtrate was collected into 
an evaporating flask and was dried using the rotary evaporator.  
 
Like the procedure in section 3-2.1 of chapter 3, the extract was partitioned between 
ethyl acetate (EtOAc) and H2O (2:1, v/v). The EtOAc portion was dried (28 mg yield) 
and suspended in 100 μL of MeOH, which was then applied to an already equilibrated 
Sep-Pak® C-18 SPE cartridge (0.7 mL, Waters, USA) to obtain six fractions [MeOH–
H2O: 0:1, 3:7, 1:1, 8:2, 1:0 (v/v) and absolute acetonitrile] (F1-6). A preliminary cell-
base assay from mouse neuroblastoma 2a cell line was performed where a test 
concentration of 100 ug/mL was applied into each well. Fractions MeOH–H2O (8:2, 1:0 
v/v) and absolute acetonitrile (F4, F5 and F6) showed cytotoxic activities with the 
highest bioactivities displayed by F4 and F5 (Figure 4-2). 
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4-2.2 Cytotoxicity Bioassay 
 
The same procedure described in section 3-2.2 of chapter 3 was performed in this 
section, except that extracts and compounds were obtained from Haliclona sp. and that 
only Neuro 2a cell line was used in the cell bioassay. Briefly, the test compounds or 
extract mixture (for preliminary test) were solubilized in DMSO and were added to the 
cells (DMSO final conc. 0.50%, v/v). The cells were cultured in the RPMI 1640 
medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine 
serum and 100 μg/mL streptomycin and 100 U/mL penicillin in 96-well plates and 
incubated at 37 °C in 5.0% of CO2 /air.  The remaining procedure was outlined in the 
scheme below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4-1. Flow diagram of the cytotoxicity test procedure.                                                                                                                  
Figure 4-2. Cytotoxicity test after Sep Pak fractionation. The 
concentration of each fraction was 100 μg/mL.                                                                                                             
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4-2.3 HPLC Purification 
 
Based on the cytotoxicity result, the fractions eluted with MeOH–H2O (8:2/1:0) were 
combined (8.8 mg) and then subjected to a Mightysil RP-18GP II column 
chromatography (10 × 250 mm, 5 μm, Kanto Chemical, Tokyo, Japan) with a stepwise 
condition: MeOH–H2O 1:1, 8:2, 9:1, and 1:0 (v/v). The UV detection (240 nm) was 
performed using a diode array detector (DAD) (Hitachi Chromaster 5430, Hitachi, 
Japan) (Figure 4-3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The bioactive fractions were screened using HR-LCMS. Upon identifying the potential 
candidates, the fractions were dried and dissolved in CD3OD (0.4 mL) for NMR 
analysis.  
 
 
 
 
 
 
Column: Mighysil RP-18 GPII 250 mm, (5μm). Kanto Chemical) 
Mobile Phase: A: MeOH, B: H
2
O. Initial 50% A, 80% A, 90% A, 
100% A (0-100 min). 1.0 mL/min 
Figure 4-3. LC-DAD chromatogram of the elution with MeOH–H2O 
(8:2/1:0) (F4–5) fractions.                                                                                                            
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4-3.0 Results/Discussion 
4-3.1 Structure Identification 
HR-ESIMS (MicrOTOF QII, Bruker Daltonics, Billerica, MA, USA) screening of the 
active fractions in the cell-based assay revealed two known stereo chemically related 
compounds corresponding to the major peak observed in the LC DAD (UV absorbance 
240 nm) (Figure 4-3). The molecular formula of 6 (S11F4F40) was determined as [M + 
H – H2O]+ C27H47O5; m/z 451.3420, and [M + Na]+ m/z 491.3341 (calcd. for 
C27H48O6Na 491.3343 (Figure 4-4) while 7 (S11F4F42) gives [M + H – H2O]+ 
C27H47O5; m/z 451.3405 and [M + Na]
+ m/z 491.3334 (calcd. for C27H48O6Na 491.3343. 
(Figure 4-5). FABMS analysis also confirmed the identical molecular formula of the 
two compounds as [M + Na]+ m/z 491.9827 (est. for C27H48O6Na) (See appendix p.110). 
 
1H NMR data comparison between 6 and 7 showed similar proton peaks except for the 
protons which accounts for their difference in stereochemistry (Figure 4-6). The 1H 
NMR signals and 13C NMR signals of 6 and 7 were comparably assigned on the basis of 
gradient COSY, TOCSY, TOCSY1D, and gradient HSQC (Figure 4-7 and 4-8) and 
HMBC spectra (See appendix p.111-118). The NMR spectral assignment of 6 and 7 are 
listed in Table 4-1. Comparison with known polyoxygenated 9-11 secosterol 
compounds revealed that 6 (although now with more precise assignment) was identified 
as herbasterol previously isolated from Dysidea herbacea.130) and 7 was identified as 
stellettasterol isolated from Stelletta sp.131)  
 
 
 
 
Figure 4-4. HR-ESI-MS of compound 6  
(S11F4F40). 
Figure 4-5. HR-ESI-MS of compound 7  
(S11F4F42). 
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Among other major signals, 13C NMR of four methyl groups in 6 and 7 were observed 
at C18 (18.5/17.6), C21 (20/19.9), C26 (22/22.6), C27 (22/22.8). The 1H NMR 
spectrum also revealed the corresponding protons of these four methyl groups at H-3 
(0.75, s, 3H/0.77, s, 3H), H-21 (1.02, d, 3H/1.0, d, 3H) and H-26 (0.88, d, 3H/0.88, d, 
3H). The only different characteristic point observed in HSQC data of 6 and 7 is the 
coupling at position C3 which accounts for their stereochemistry. NMR spectral data of 
6 via gradient HSQC revealed coupling at C3/H3 (73/3.22) (Figure 4-7) while that of 7 
was C3/H3 (69/ 3.83) (Figure 4-8). The coupling assigned for methine and the 
oxygenated methine proton at position C3 of 6 and 7 correlate well with known 
compounds herbasterol and stellettasterol respectively. As suggested by Li H, et al.131) 
referring to stellettasterol, the absolute configuration at C3 deviates from herbasterol C3 
in that the coupling constant of 11.6 Hz between H1 and H2 and that of 2.9 Hz between 
H2 and H3 indicated that H2 and H3 are axial and equatorial respectively (Figure 4-9 
and 4-10)  
 
 
 
 
 
 
 
 
 
Figure 4-6. 1H NMR spectra of S11F4F40 (6) and S11F4F42(7). 
S11F4F40 (6)  
S11F4F42 (7)  
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1H NMR (600 MHz), 13C NMR (151 MHz). ND represents “not determined”.                                                                                                                             
Table 4-1. NMR spectroscopic data of S11F4F40 and S11F4F42 in CD3OD.  
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Figure 4-7. HSQC spectrum of 6. 
Figure 4-8. HSQC spectrum of 7. 
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Figure 4-9. Comparison of 6 and with herbasterol.130) 
Figure 4-10. Comparison of 7 and stellettasterol.131) 
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4-3.3 Cytotoxic Activity Test 
In light of the difference in stereochemistry at position C3 of 6 and 7, assay using Neuro 
2a cells cytotoxicity showed that 6 displayed slightly stronger cytotoxic effect with IC50 
of 9.4 μg/mL compared to 7 with IC50 of > 9.4 μg/mL (Figure 4-11) Since both 6 and 7 
were isolated from the same marine sponge (Haliclona sp.), while herbasterol and 
stellettasterol were obtained from two different marine sponges Dysidea herbacea and 
Stelletta sp. respectively, it would be interesting if other studies highlight their 
biogenetic origins and the roles these polyoxygenated 9-11 secosterol compounds play 
in these marine sponge species.  
 
 
  
Figure 4-11. Preliminary cytotoxicity activity of 6 (A) and 7 (B). 
A B 
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4-4.0 Conclusion 
Screening of a portion of marine sponge Haliclona sp. yielded compounds 6 and 7, 
which (on the basis of spectral comparison) were believed to be known polyoxygenated 
9-11 seco-steroids herbasterol and stellettasterol, respectively. A preliminary 
cytotoxicity studies on these two stereo chemically different isomers of 6 (herbasterol) 
and 7 (stellettasterol) showed an IC50 of almost 10 μg/mL. 
  
92 
 
Appendices 
Selected Toxic Profiles from the Solomon Islands specimens 
 
 
 
 
 
Toxic profile from EtOH extract of the skin of A. nigropunctatus No.3  
from the Solomon Islands. 
Toxic profile from flesh of A. hispidus No.3 from the Solomon Islands. 
93 
 
 
 
 
  
No TTX was detected in the skin of D. holocanthus No. 1 from the Solomon 
Islands. 
 
No TTX was detected in the skin of D. holocanthus No. 1 from the Solomon 
Islands. 
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NMR data for Chapter 3 
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The gradient HMBC spectrum (CD
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24 11 
26 27 
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The gradient COSY spectrum (CD
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The gradient TOCSY spectrum (CD
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OD, 600 MHz, ni = 128) of 2.  
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26 27 21 19 
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The gradient HSQC spectrum (CD
3
OD, 600 MHz, ni = 128) of 2.  
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The gradient HMBC spectrum (CD
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OD, 600 MHz, ni = 128) of 2.  
24 
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Irradiation at Xyl-1’ (4.35 ppm) 
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Xyl-1’ (4.35 ppm) 
signal of 1. 
sarasinoside M
2
 (1) 
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Xyl-1’ (4.35 ppm) 
signal of 2. 
sarasinoside B
1
 (2) 
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Irradiation at GlcNac-1’’ (4.87 ppm) 
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of GlcNAc-1’’ signal 
(4.87 ppm) of 1. 
sarasinoside M
2
 (1) 
TOCSY 1D spectrum (CD
3
OD, 600 MHz,) irradiation of GlcNac-1’’ signal 
(4.87 ppm) of 2.  
sarasinoside B
1
 (2) 
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Xyl
2
-1’’’ signal 
(5.05 ppm) of 2.  
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Xyl
2
-1’’’ signal 
(5.05 ppm) of 1.  
Irradiation at Xyl
2
-1’’’ (5.05 ppm) 
sarasinoside M
2
 (1) 
sarasinoside B
1
 (2) 
107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Glc-1’’’’ signal 
(4.65 ppm) of 1.  
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of Glc-1’’’’ signal 
(4.65 ppm) of 2.  
Irradiation at Glc-1’’’’ (4.65 ppm) 
sarasinoside M
2
 (1) 
sarasinoside B
1
 (2) 
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TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of GalNAc-1’’’’’ signal 
(4.53 ppm) of 1. 
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of GalNAc-1’’’’’ signal 
(4.53 ppm) of 2. 
Irradiation at GalNAc-1’’’’’ (4.53 ppm) 
sarasinoside M
2
 (1) 
sarasinoside B
1
 (2) 
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TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of GlcNAc-6’’ signal 
(4.11 ppm) of 1. 
TOCSY 1D spectrum (CD
3
OD, 600 MHz) irradiation of GlcNAc-6’’ signal 
(4.11 ppm) of 2. 
Irradiation at GlcNAc-6’’ (4.11 ppm) 
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FABMS data for Chapter 4 
 
  
The FABMS spectrum of 6. 
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NMR data for Chapter 4 
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The gradient COSY spectrum (CD
3
OD, 600 MHz, ni = 128) of 6. 
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The gradient HSQC spectrum (CD
3
OD, 600 MHz, ni = 128) of 6.  
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The gradient HMBC spectrum (CD
3
OD, 600 MHz, ni = 128) of 6.  
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The 
1
H NMR spectrum (CD
3
OD, 600 MHz) of 7. 
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The gradient COSY spectrum (CD
3
OD, 600 MHz, ni = 200) of 7. 
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The gradient HSQC spectrum (CD
3
OD, 600 MHz, ni = 128) of 7.  
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The gradient HMBC spectrum (CD
3
OD, 600 MHz, ni = 128) of 7.  
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